| A Case series and case reports |
|
| A2 |
Razenberg |
Churg-Strauss syndrome in a pediatric patient |
|
| A3 |
Vanfleteren |
Fatal drug-induced interstitial pneumonitis associated with amitriptyline and clozapine drug-drug interactions |
|
| A11 |
Ottink |
A child with idiopathic pulmonary hemosiderosis and celiac disease: A causative mechanism? |
|
| |
|
|
|
| B Genetics and mechanisms in sarcoidosis |
| B6 |
Videnovic–Ivanov |
Glicoregulation in patients with sarcoidosis |
|
| |
|
|
|
| C Diagnostic tools in sarcoidosis: What is new? |
|
| C2 |
Mostard |
Association of HRCT findings with pulmonary PET activity in sarcoidosis |
|
| C3 |
Mostard |
Bone and bone marrow involvement in sarcoidosis as detected by F18 FDG-PET/CT |
|
| C6 |
Videnovic-Ivanov |
Fluorodeoxyglucosae positron emission tomography scans in sarcoidosis |
|
| C7 |
Vucinic-Mihailovic |
Neurosarcoidosis: MRI and CSF findings in our patients |
|
| C8 |
Filipovic |
Chitotriosidase – reliable test for sarcoidosis activity |
|
| C11 |
Kempisty |
Interferon γ release assays are useful to exclude M. tuberculosis infection in sarcoidosis patients with positive tuberculin skin test |
|
| C12 |
Cremers |
Assessment of prevalence and severity of hepatic involvement in sarcoidosis |
|
| |
|
|
|
| D Treatment options in sarcoidosis |
| D2 |
Erckens |
Successful treatment with adalimumab of sarcoidosis patients with chronic non-infectious uveitis |
|
| D3 |
Drijkoningen |
Successful treatment of multi-organ refractory sarcoidosis with adalimumab |
|
| D5 |
Kock |
Infliximab in refractory sarcoidosis: the ild care experience |
|
| D6 |
Vucinic |
Steroid therapy and metabolic syndrome in patients with sarcoidosis |
|
| |
|
|
OK |
| E Impact of Sarcoidosis in patients’ lives |
| E1 |
de Kleijn |
Measurement of fatigue in sarcoidosis: Defining minimal clinically important differences |
|
| E2 |
de Kleijn |
Three types of fatigue in sarcoidosis patients |
|
| E5 |
Vucinic |
“Pride and prejudice” in sarcoidosis. Does a prescribed treatment match a patient’s priorities? |
|
| E6 |
Filipovic |
The coexistence between fatigue and oxidative stress – total antioxidant status (TAS) in sarcoidosis |
|
| E7 |
Vucinic |
Transcranial ultrasound (TCS) in sarcoidosis- relation to fatigue, depression, and anxiety |
|
| E10 |
Mizuno |
Cutaneous lesions of sarcoidosis in Japan |
|
| |
|
|
|
| F Pulmonary fibrosis and other ild |
| F1 |
Wijnen |
Diffuse alveolar hemorrhage associated with variant alleles increases the risk of pulmonary fibrosis in patients using oral anticoagulants |
|
| F11 |
Hendriks |
Bronchogenic carcinoma in idiopathic pulmonary fibrosis patients after lung transplantation |
|
| |
|
|
|
| G Inflammation: Serum, BAL, and induced sputum in sarcoidosis |
| G2 |
Oswald-Richter |
CD8+ T cell exhaustion in sarcoidosis disease |
|
| G5 |
Patterson |
Circulating cytokines in sarcoidosis |
|
| G6 |
Smojver-Ježek |
Differences in BAL macrophages cytology determined by morphometric analysis in patients with sarcoidosis |
|
| |
|
|
|
| H Inflammation: Serum, BAL, and induced sputum in ild |
| H3 |
Vanspauwen |
Presence of mimivirus in bronchoalveolar lavage fluid of critically ill patients suspected of ventilator-associated pneumonia |
 |
| H4 |
Schnabel |
Alternative diagnosis in the ventilator-associated pneumonia suspected bronchoalveolar lavage negative patient |
|
| H5 |
Osolnik |
Diagnostic value of pulmonary NKT CD3+CD16/56+ cells |
|
| H6 |
Stark |
Induced sputum analyses in Beryllium-exposed dental technicians reflect hygiene and oxidative stress |
|
| H7 |
Takahashi |
Levels of autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) are elevated in the sera of pneumoconiosis patients |
|
Announcements
